28th December 2020
Robert Lavine
The chemical analysis device developer has added $20m to an initial public offering following $70m in funding from investors including Utec.
27th December 2020
Thierry Heles
Bar-Ilan University’s textile developer Sonovia has completed an $18.5m initial public offering on the Tel Aviv Stock Exchange.
23rd December 2020
Robert Lavine
UTokyo Innovation Platform has scored an exit as the online investment platform developer went public on the Tokyo Stock Exchange.
17th December 2020
Robert Lavine
The UBC-linked antibody drug developer has added $73m to its initial public offering, and its shares are still trading at more than double the IPO price.
14th December 2020
Robert Lavine
Shares in the antibody discovery platform developer, advancing UBC research, opened at more than three times their IPO price to net it a valuation topping $15bn.
9th December 2020
Callum Cyrus
ETH Zurich-founded HeiQ chose the London Stock Exchange for its listing having posted a $10.9m operating profit for the first half of the year.
19th November 2020
Robert Lavine
Berkeley Catalyst Fund-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.
17th November 2020
Robert Lavine
Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.
